|Day Low/High||14.08 / 14.26|
|52 Wk Low/High||7.83 / 11.88|
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
The central bank exempted mid-sized companies from the "qualitative" part of stress tests that determine whether the companies can pay dividends and buy back stock in the coming year.
We used a price decline to add to our position in TherapeuticsMD this week.
The company saw solid growth in commercial and industrial loans and deposits.
We'll be listening tomorrow for management’s 2017 interest rate outlook.
The advisers stand to benefit if the sector sees more deal activity under Trump.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
Regional banks may get the urge to merge if Congress relaxes some regulations this year.
Congress will seek to wipe out or make changes to the Dodd-Frank Act in small chunks, with a focus first on providing relief for mid-sized regional institutions.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
Here are Tuesday's top research calls, including an upgrade for Western Digital and new coverage for Ciena, Salesforce and Square.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
Shareholders of CalAtlantic, Huntington Bancshsares and Synovus Financial all will qualify for dividends this week.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.
President-elect Donald Trump has nominated ex-Goldman Sachs partner Steve Mnuchin as Treasury Secretary -- the latest in an emerging list of divisive administration picks.
Builders FirstSource, Huntington Bancshares and TherapeuticsMD all received upbeat outlooks from analysts overnight.
These 2 names have positive fundamental characteristics, but have lagged the broader market in recent weeks.
We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.
A popular strategy is to piggy-back purchases revealed in 13F SEC filings.
The Republican sweep of Congress is a clearly positive result for deals between mid-sized banks, but a negative for the biggest financial institutions.